Petros Pharmaceuticals, Inc. (PTPI) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-53.25 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.02 vs 预期 $-53.25 (超预期 +100%). 分析师准确度: 0%.
EPS 预测 — PTPI
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$0.02
vs Est –$53.25
▲ 232,432.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — PTPI
94%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.005B
vs Est $0.005B
▼ 6.3% off
Revenue Trend
Analysts expect stable revenue going forward.
